See more : Lalin Property Public Company Limited (LALIN.BK) Income Statement Analysis – Financial Results
Complete financial analysis of Ra Medical Systems, Inc. (RMED) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Ra Medical Systems, Inc., a leading company in the Medical – Devices industry within the Healthcare sector.
You may be interested
- mCloud Technologies Corp. (MCLDF) Income Statement Analysis – Financial Results
- Clarim Acquisition Corp. (CLRMW) Income Statement Analysis – Financial Results
- Silver Lake Resources Limited (SVLKF) Income Statement Analysis – Financial Results
- F5, Inc. (FFIV) Income Statement Analysis – Financial Results
- Nihon Tokushu Toryo Co., Ltd. (4619.T) Income Statement Analysis – Financial Results
Ra Medical Systems, Inc. (RMED)
About Ra Medical Systems, Inc.
Ra Medical Systems, Inc., a medical device company, develops, manufactures, and markets excimer lasers for use in the treatment of vascular immune-mediated inflammatory diseases. It offers destruction of arteriosclerotic blockages by laser radiation ablation, a minimally invasive excimer laser and single-use catheter system that is used by physicians in the endovascular treatment of vascular blockages resulting from lower extremity vascular disease. The company sells its products primarily through distributors in the United States. Ra Medical Systems, Inc. was incorporated in 2002 and is headquartered in Carlsbad, California.
| Metric | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|
| Revenue | 14.00K | 22.00K | 4.41M | 7.20M | 6.26M | 5.87M | 5.98M |
| Cost of Revenue | 161.00K | 1.56M | 5.48M | 8.85M | 4.21M | 4.17M | 3.14M |
| Gross Profit | -147.00K | -1.54M | -1.08M | -1.65M | 2.05M | 1.71M | 2.84M |
| Gross Profit Ratio | -1,050.00% | -6,990.91% | -24.45% | -22.93% | 32.78% | 29.05% | 47.49% |
| Research & Development | 6.39M | 12.25M | 9.01M | 4.53M | 2.78M | 4.52M | 1.72M |
| General & Administrative | 2.23M | 0.00 | 0.00 | 0.00 | 30.44M | 0.00 | 0.00 |
| Selling & Marketing | 1.25M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 16.25M | 15.48M | 25.97M | 51.55M | 30.44M | 14.95M | 5.32M |
| Other Expenses | 99.00K | 2.01M | 21.00K | 788.00K | 338.00K | 0.00 | 0.00 |
| Operating Expenses | 22.64M | 27.73M | 34.98M | 56.08M | 33.21M | 19.47M | 7.04M |
| Cost & Expenses | 22.80M | 29.29M | 40.46M | 64.93M | 37.42M | 23.63M | 10.17M |
| Interest Income | 0.00 | 0.00 | 129.00K | 1.04M | 352.00K | 0.00 | 0.00 |
| Interest Expense | 3.08M | 0.00 | 108.00K | 250.00K | 14.00K | 4.00K | 3.00K |
| Depreciation & Amortization | 8.77M | 1.57M | 2.37M | 1.75M | 624.00K | 218.00K | 95.00K |
| EBITDA | -18.20M | -29.27M | -36.06M | -57.73M | -31.16M | -17.54M | -4.10M |
| EBITDA Ratio | -129,971.43% | -133,027.27% | -818.59% | -801.92% | -498.00% | -298.84% | -68.66% |
| Operating Income | -26.96M | -29.27M | -36.06M | -57.73M | -31.16M | -17.76M | -4.20M |
| Operating Income Ratio | -192,578.57% | -133,027.27% | -818.59% | -801.92% | -498.00% | -302.56% | -70.25% |
| Total Other Income/Expenses | 3.00K | 2.01M | 21.00K | 788.00K | 338.00K | -4.00K | -3.00K |
| Income Before Tax | -26.86M | -27.26M | -36.04M | -56.94M | -30.82M | -17.76M | -4.20M |
| Income Before Tax Ratio | -191,871.43% | -123,895.45% | -818.12% | -790.97% | -492.60% | -302.62% | -70.30% |
| Income Tax Expense | 3.00K | 4.00K | 7.00K | 15.00K | 10.00K | 1.00K | 1.00K |
| Net Income | -26.87M | -27.26M | -36.05M | -56.96M | -30.83M | -17.77M | -4.20M |
| Net Income Ratio | -191,892.86% | -123,913.64% | -818.27% | -791.18% | -492.76% | -302.64% | -70.31% |
| EPS | -25.98 | -269.91 | -1.06K | -5.42K | -4.18K | -1.83K | -433.96 |
| EPS Diluted | -25.98 | -269.91 | -1.06K | -5.42K | -4.18K | -1.83K | -433.96 |
| Weighted Avg Shares Out | 1.03M | 101.00K | 33.98K | 10.52K | 7.38K | 9.68K | 9.68K |
| Weighted Avg Shares Out (Dil) | 1.03M | 101.00K | 33.98K | 10.52K | 7.38K | 9.68K | 9.68K |
Ra Medical Systems Enters Into Definitive Merger Agreement with Catheter Precision
CARLSBAD, Calif.--(BUSINESS WIRE)--Ra Medical Systems announces definitive merger agreement with Precision Catheter.
Penny Stocks To Watch: Why KRKR, RMED, TYME, TTNP & ENDP Stock Are Moving
Penny stocks to watch with news The post Penny Stocks To Watch: Why KRKR, RMED, TYME, TTNP & ENDP Stock Are Moving appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Why Ra Medical Systems Shares Are Trading Higher Today?
The FDA has cleared RA Medical Systems Inc's (NYSE: RMED) DABRA 2.0 catheter as part of the DABRA Excimer Laser System. This next-generation DABRA catheter features enhancements, including a braided over jacket design intended to improve deliverability and kink resistance.
Ra Medical Systems, Inc. (RMED) CEO Will McGuire on Q1 2022 Results - Earnings Call Transcript
Ra Medical Systems, Inc. (NYSE:RMED ) Q1 2022 Earnings Conference Call May 16, 2022 4:30 PM ET Company Participants Bruce Voss - LHA Will McGuire - Chief Executive Officer Andrew Jackson - Chief Financial Officer Conference Call Participants Jeffrey Cohen...
Ra Medical Systems Reports First Quarter 2022 Financial Results
CARLSBAD, Calif.--(BUSINESS WIRE)--Ra Medical Systems, Inc. (NYSE American: RMED) (“Ra Medical” or “the Company”), a medical device company focusing on developing its excimer laser system to treat vascular disease, reports financial results for the three months ended March 31, 2022...
Ra Medical Systems to Report First Quarter 2022 Financial Results on May 16, 2022
CARLSBAD, Calif.--(BUSINESS WIRE)--Ra Medical Systems, Inc. (NYSE American: RMED) announces that it will report financial results for the three months ended March 31, 2022 after market close on Monday, May 16. Ra Medical management will hold an investment community conference...
Ra Medical Systems, Inc. (RMED) CEO Will McGuire on Q4 2021 Results - Earnings Call Transcript
Ra Medical Systems, Inc. (RMED) CEO Will McGuire on Q4 2021 Results - Earnings Call Transcript
Ra Medical Systems Reports 2021 Fourth Quarter and Full Year Financial Results
CARLSBAD, Calif.--(BUSINESS WIRE)--Ra Medical Systems, Inc. (NYSE American: RMED), a medical device company focusing on developing its excimer laser system to treat vascular disease, reports financial results for the three months and full year ended December 31, 2021 and provides...
Best Penny Stocks To Buy? 4 Biotech Stocks To Watch Right Now
Biotech penny stocks to watch right now. The post Best Penny Stocks To Buy?
5 Penny Stocks Under $1 To Buy According To Redditors This Week
Reddit penny stocks under $1 to watch this week. The post 5 Penny Stocks Under $1 To Buy According To Redditors This Week appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Source: https://incomestatements.info
Category: Stock Reports